INS and type 2 diabetes mellitus: It was demonstrated that it presents anticancer activity towards the non-small cancer lung cell (NSCLC) lines, and was able to induce insulin release from rat- and human-derived beta cells with potential use for type 2 diabetes treatment [55,56].